Release Date: 22/06/21 14:31 Summary: Response to ASX Price Query Price Sensitive: Yes Download Document 343.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%